We intend to search globally for a target with operations or prospects focusing on high-growth healthcare, consumer and technology sectors, and companies that we believe can be well-positioned for success in Greater China. (Incorporated in the Cayman Islands)  The Greater China region is where our sponsor has built an unparalleled proprietary network and resources, which […]

(Note: Digital Brands Group, Inc. priced its small-cap unit offering on May 13, 2021, at $4.15 – below its proposed offering price of $5 – on 2.4 million units, up from 2 million units in its prospectus. Each unit consists of one share of common stock and one warrant to buy one share of common […]

Our management team and the investment professionals at Fortinbras have extensive experience in balance sheet restructurings, rescue financings, corporate carve-outs, liability management, and operational turnarounds. We believe this experience to be a substantial competitive advantage in the current economic environment relative to other blank check companies and sources of capital. The recent novel coronavirus (“COVID-19”) […]

We intend to focus our efforts on evaluating business combination targets by leveraging our connections with a variety of family offices, investment funds, and operating businesses. We expect to also take advantage of our sponsor’s extended network with Asian consumer markets by enabling potential business combination targets producing quality products in North America to tap […]

We intend to concentrate on identifying businesses that provide technologically innovative solutions to the real estate industry, broadly defined as “PropTech.” Shelter is a SPAC focused on the PropTech sector seeking to deliver a high growth company that leverages disruptive technology to enact positive change in the real estate ecosystem. (Note: Shelter Acquisition Corp. I […]

We are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Our lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to […]

(IPOScoop has “NO CALL” on this offering because it is NOT a traditional IPO. This is a direct listing on the New York Stock Exchange. This offering does not have underwriters. Instead, the investment banks named here are acting as financial advisors.) *Note: The NYSE set a reference price of $18.00 for the ZipRecruiter direct listing, […]

TransCode Therapeutics is an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics. We have created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. Our lead therapeutic candidate, […]

Biotech and life sciences companies are the intended acquisition targets of this new blank check company. (Incorporated in the Cayman Islands.)

We cultivate and process natural, medicinal-grade cannabis oil and high quality cannabis derived medical and wellbeing products and intend to supply these premium products to large channel distributors, including pharmacies, medical clinics, and cosmetic companies. We are an early-stage private company headquartered in Canada.  Our agricultural and processing operations are in Colombia.  We are an […]